
March Madness - Coast To Coast To Attend SOT And DCAT
I recently had the opportunity to attend two different events — the Society of Toxicology ToxExpo (SOT) and the Drug, Chemical, and Associated Technologies Week (DCAT). By Rob Wright
Continue Reading..

Why I'll Go Back To Partnerships In Clinical Trials
The annual Partnerships in Clinical Trials event took place March 4 to 7 in Orlando, FL. It kicked off on Sunday with a Women’s Clinical Leadership Forum. As I was unable to attend this part of the conference I sought insight from those who did. By Rob Wright
Continue Reading..

Ever Heard Of The HBA?
Last year I attended the Healthcare Businesswomen’s Association (HBA) Woman of The Year (WOTY) Annual Luncheon in New York City. I was so impressed with the caliber of people involved with this organization as well as the size and scope of the WOTY event.
Continue Reading..

Getting Informed At Informex
InformexUSA started out as a show with strictly tabletop exhibits. Twenty-eight years later, this event features nearly 500 exhibitors and nearly 4,000 attendees all focused on the global chemical market. By Rob Wright
Continue Reading..

Want To Work With The Military Toward Drug Development?
I recently spoke with someone who signed a cooperative R&D agreement with a military organization. Getting the federal government to put their vast resources behind developing your drug may seem like a no-brainer. By Rob Wright
Continue Reading..
Can A Non-Scientist Run A Biotech?
I recently posed this very question to Brian O’Callaghan, president and CEO of biotech company Sangart.
Continue Reading..

Leaders Don't Puke
Ron Karr is a popular public speaker and business development expert. He is also the author of “Lead, Sell Or Get Out Of The Way.” He and I recently had a discussion about his book as I was interested in having him submit an article for Life Science Leader’s very popular Leadership Lessons column. By Rob Wright
Continue Reading..

Does Drug Delivery Partnerships Deliver?
Las Vegas served as the host city for this year’s Drug Delivery Partnerships’ (DDP) conference. Unlike most outings to “Sin City,” when it comes to this conference, Sesha Neervannan, Ph.D., VP pharmaceutical development with Allergan (NYSE: AGN) advises that what happens in Vegas SHOULD NOT stay in Vegas, because there was too much good content at this event. I echo his sentiment. By Rob Wright
Continue Reading..

Is Our Content Relevant
Not too long ago, I was contacted by a marketing manager of one of the top CMOs. He wanted to pick my brain to help enhance the company’s knowledge of industry trends with the goal of staying ahead of the competition. By Rob Wright
Continue Reading..

Conversation With Clinical Data Consolidation Guru
At a number of shows this past year, I was exposed to some of the issues surrounding data. By Rob Wright
Continue Reading..
This website uses cookies to ensure you get the best experience on our website. Learn more